Investigational Site Number 276002

Münster 48149

0 studies enrolling now · 3 studies all time

What they study most

Acid Maltase Deficiency, Glycogen Storage Disease Type II (GSD II), Glycogen Storage Disease Type II Pompe Disease, Multiple Sclerosis Relapse, Pompe Disease

Studies at this site

• Avalglucosidase Alfa Extension Study — Completed
• Safety and Efficacy Evaluation of Repeat neoGAA Dosing in Late Onset Pompe Disease Patients. — Completed
• Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis and Treated With Interferon-beta — Stopped early